Chemoradiotherapy in Unresectable Esophageal Cancer

Clinical trial NCT04278287 · RECRUITING

Trial details

NCT number: NCT04278287
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Chemoradiotherapy Albumin-bound Paxlitaxel Unresectable Malignant Neoplasm

Start date: 2019-10-01
Primary completion: 2025-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.